Standout Papers

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a ra... 2012 2026 2016 2021 395
  1. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial (2012)
    Conroy Wong, Lata Jayaram et al. The Lancet

Immediate Impact

1 from Science/Nature 60 standout
Sub-graph 1 of 21

Citing Papers

Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
2024 Standout
Lung microbiome: new insights into the pathogenesis of respiratory diseases
2024 Standout
12 intermediate papers

Works of Paul Sexton being referenced

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
2012 Standout
Pulmonary fibroblasts from COPD patients show an impaired response of elastin synthesis to TGF-β1
2011

Author Peers

Author Last Decade Papers Cites
Paul Sexton 437 148 9 229 10 645
E.H.J. van Haren 540 101 10 168 9 734
Hilary Wyatt 540 87 14 119 20 692
M. Wickremasinghe 382 72 8 287 13 588
Bertrand Delaisi 294 122 5 148 23 523
Steven Cowman 301 43 6 405 17 687
A Equi 414 91 2 173 7 533
F Holland 204 214 3 202 12 514
A C Harrison 276 317 2 126 17 598
Fernando Verra 341 91 75 241 16 656
Katarina Chadelat 360 107 5 55 13 561

All Works

Loading papers...

Rankless by CCL
2026